News

November 9, 2016November 9, 2016

Obesity Causes Rheumatoid Arthritis to Develop Earlier, Delays Treatment Effect in Mice

News

New research in mice shows that obesity causes rheumatoid arthritis (RA) to develop earlier, and may play a role in slowing the effect of anti-TNF-alpha antibody drugs, the current standard medication ... Read more

November 7, 2016November 7, 2016

Baricitinib Enhances RA Patients’ Outcomes in Phase 3 Trial

News

Patients with rheumatoid arthritis (RA) and inadequate responses to biological disease-modifying antirheumatic drugs (bDMARDs) show a positive response to treatment with baricitinib (LY3009104), with the therapy improving several patient-reported outcomes, ... Read more

November 4, 2016November 4, 2016

Biosimilar of Humira for Rheumatoid Arthritis Passes Critical Phase 3 Trial

News, rheumatoid arthritis

Boehringer Ingelheim‘s BI 695501 has been deemed effectively equivalent to Humira (adalimumab) in patients with active rheumatoid arthritis (RA), according to the results of a crucial Phase 3 clinical trial comparing the two ... Read more

October 26, 2016October 26, 2016

Cimzia AutoClicks Prefilled Pen for RA, Other Types of Arthritis, Now Available in UK

News

The Cimzia (certolizumab pegol) AutoClicks Prefilled Pen was just made available in the United Kingdom through the National Health System (NHS), announced UCB, a company focused on neurology and immunology disorders. Designed ... Read more

October 24, 2016October 24, 2016

Pfizer to Begin Shipping Inflectra for RA, Other Illnesses to US Wholesalers in November

News

Pfizer recently announced that its Inflectra (infliximab-dyyb) for injection will be shipped to U.S. wholesalers in late November. Inflectra is a biosimilar of Remicade (infliximab), and is the first FDA approved biosimilar monoclonal antibody ... Read more

October 21, 2016October 21, 2016

Ablynx Concludes Phase 2 Trials of RA Therapy, Losing Partner AbbVie in the Process

News

Ablynx is about to wrap up its Phase 2 trials of vobarilizumab (ALX-0061) for patients with rheumatoid arthritis, and is discussing a move toward Phase 3 studies with U.S. and European ... Read more

October 19, 2016October 19, 2016

Wheat Protein May Be Linked to Inflammation in Rheumatoid Arthritis, Study Says

News

Inflammation in people with rheumatoid arthritis may be promoted by a group of proteins, called amylase-trypsin inhibitors (ATIs), that are commonly found in wheat, researchers reported. ATIs might also play a role in ... Read more

October 17, 2016October 17, 2016

Early Rheumatoid Arthritis, Bone Loss Linked to Autoantibodies

News

The presence of certain autoantibodies in rheumatoid arthritis (RA) is linked to bone loss in patients with early disease, suggesting that bone remodeling in rheumatoid arthritis is directly connected to autoimmunity. ... Read more

October 14, 2016October 14, 2016

$1.1M Grant Awarded to Study Effects of Aging on New Blood Vessels; May Help Guide Future RA Therapies

News

A Tulane University research team received a National Institutes of Health (NIH) grant of $1.1 million to study the effects of aging on the growth of new blood vessels, a ... Read more

October 10, 2016October 10, 2016

Feinstein Institute CEO Honored with Frederik Bang Award for Work into Immune System

News

Kevin J. Tracey, MD, chief executive officer and president of the Feinstein Institute for Medical Research, has been awarded the Frederik B. Bang Award — the highest honor given by the International Endotoxin and ... Read more